Protein Molecular Motif Comparison Studies on Lung and Colon Cancer Genes (CHRNA3 and MLH1) using In-silico Protocols

International Journal of Novel Trends in Pharmaceutical Sciences,2014,4,5,119-124.
Published:October 2014
Type:Research Article
Authors:
Author(s) affiliations:

J. Amose1, Balaji2 and John William1

1Department of Zoology, Loyola College, Chennai, Tamil Nadu, INDIA.

2Director, Akshaya Computational Medicine Pvt ,Ltd., Chennai, Tamil Nadu, INDIA.

Abstract:

Worldwide, lung cancer is the most common cancer among men in terms of both incidence and mortality, and among women has the third highest incidence, and is second after breast cancer in mortality. In 2012, there were 1.82 million new cases globally, and 1.56 million deaths due to lung cancer, representing 19.4% of all deaths from cancer. The highest rates are in North America, Europe and East Asia, with over a third of new cases in 2012 in China.. Globally more than 1 million people get colorectal cancer every year resulting in about 715,000 deaths as of 2010 up from 490,000 in 1990. As of 2012 it is the second most common cause of cancer in women (9.2% of diagnoses) and the third most common in men (10.0%) with it being the fourth most common cause of cancer death after lung, stomach and liver cancer. We finally prove that the identified motif and the molecular conserved regions are the best targets for drug docking studies.

Downloads: 
In-page image(s): 

Motif prediction meme software tool – (CHRNA3 and MLH1)